Denifanstat for moderate to severe acne
Part of Skin clinical trials.
This trial tests an experimental pill called denifanstat to see if it can clear up moderate to severe acne. If you qualify, you may receive the study drug or a placebo, and researchers will check how well it works on your skin over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be at least 12 years old
- Have moderate to severe acne with a certain number of pimples and bumps on your face (30 to 75 inflamed, 30 to 100 non-inflamed)
- Not have more than 2 facial cysts or nodules, or have certain severe forms of acne
- No significant eye problems like chronic dry eye
- Will need to use highly effective birth control if you could become pregnant, or be sexually abstinent
- No recent use of certain acne treatments unless you've had a washout period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination hormonal pill (a progestogen and low-dose estrogen) to treat moderate acne in women. It may be an option if you have not had success with other acne treatments.
This trial is testing a new spray called B244 that you put on your face to help treat moderate to severe acne. It aims to see if it is safe, works well, and is comfortable to use.
This trial tests a cream called KR230109 for mild to moderate facial acne. The goal is to see if the cream is safe and helps reduce pimples and blackheads/whiteheads. You will be asked to use the cream as directed and attend study visits.
This study tests a new medication called HB0043 for people with mild to moderate facial acne. It aims to see if the treatment is safe and effective in reducing acne.
This trial studies whether putting antibiotic creams on mild-to-moderate facial acne reduces inflammation. It may help answer whether topical erythromycin or clindamycin can improve acne-related redness and swelling.
This study compares three different gels for treating mild to moderate acne on the face. One gel contains standard acne medication, another adds a steroid, and the third uses a special ingredient from stem cells (called secretome) to see which works best and is safest.
Hear when a new Acne Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.